Sage Journals: Discover world-class research

Retricted access

Research article

First published 2020-6

The impact of corticosteroid use during anti-PD1 treatment

Eva Y Pan, Man Yee Merl, Katherine Lin

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2010-9-2

PD1 Negative and PD1 Positive CD4+ T Regulatory Cells in Mild Cognitive Impairment and Alzheimer's Disease

Marina Saresella, Elena Calabrese, Ivana Marventano [...]

Journal of Alzheimer’s Disease

Open access

Research article

First published 2020-7

Is Weak Acid Beneficial for Addressing Checkpoint Inhibitor–Triggered Cancer Hyper Progression in Anti-PD1/PD-L1 Immunotherapies?

Yulin Wan, Shanshan An, Yanchao Zhou [...]

Cancer Control

Retricted access

Article commentary

First published 2019-1

Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?

Constantin A Dasanu, Michael Del Rosario, Ion Codreanu [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2021-6

Accelerated cellular rejection with prominent interstitial hemorrhage following cemiplimab treatment: How can we approach a renal transplant recipient under anti-PD1 therapy?

Evelyn Hermida-Lama, Diana Rodriguez, Elena Cuadrado [...]

Journal of Onco-Nephrology

Open access

Research article

First published 2022

A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy

Emma Bigelow, Suchi Saria, Brian Piening [...]

Cancer Informatics

Retricted access

Research article

First published 2020-06

Defective Antigen Presentation Leads to Upregulation of PD1 and IL-10 in HIV-TB Co-Infection

Sharada Ramaseri Sunder, Naveen Chandra Suryadevara, Satya Sudheer Pydi [...]

Journal of Interferon & Cytokine Research

Open access

Review article

First published 2023

What is the optimal duration,dose and frequency for anti-PD1 therapy of non-small cell lung cancer?

Chii Yang Kuah, Robert Monfries, Matteo Quartagno [...]

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2020-3

Complete responses to two different anti-PD1 agents in a metastatic melanoma patient

Saadettin Kilickap, Deniz C Guven, Oktay H Aktepe [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2021

Association of immune-checkpoint inhibitors and the risk of immune-related colitis among elderly patients with advanced melanoma: real-world evidence from the SEER–Medicare database

Abdulaali R. Almutairi, Marion Slack, Brian L. Erstad [...]

Therapeutic Advances in Drug Safety

Search results